RxDoctor Payments Data

Thomas Ilustrisimo, DO

Internal Medicine · Henderson, NVNPI 1184280497

Payments from drug & device makers

$774in general payments, 2019–2025

Across 24 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$145
  • Intuitive Surgical$123
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$118
  • Chiasma, Inc.$117
  • Novartis$92
  • Pfizer$74
  • plus $104 from 5 others

What the payments were for

  • Food & beverage$774100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$774 in reported general payments places this provider in the 65th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$283,638
Medicare patients
983
Services billed
2,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$20,562
Midodrine Hcl16$691
Levetiracetam11$644
Albuterol Sulfate HfaAlbuterol Sulfate24$594
Pantoprazole Sodium60$554
Atorvastatin Calcium55$484
Amiodarone Hcl16$256
Sucralfate16$240
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$196
ClopidogrelClopidogrel Bisulfate22$172
Doxycycline Monohydrate20$168
Cefdinir14$168
Metoprolol Succinate26$154
Doxycycline Hyclate15$114
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$20,56236 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,071 internal medicine providers in Nevada.

Other internal medicine in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →